|
|
|
June 2006
Atherotech (maker of the VAP® cholesterol test) recently featured Lindora, the VAP test, and Lindora’s Medical Director, Dr. Sabina Kobylinski, in Atherotech’s Clinical Update. The article, “Lindora Medical Clinics Use VAP Cholesterol Test to Help Patients Achieve ‘Metabolic Equilibrium’, details the components of the VAP test and its advantages, as well as Lindora’s Metabolic Fitness Treatment Program™. To read the full article in .pdf format, click here.
|
|
|
April 2006
Read about the latest research on the health effects of visceral “belly” fat—and how best to lose it. The article discusses the importance of regularly monitoring the fat around one’s middle. Lindora patient John Fiore—who recently lost 67 pounds— talks about his now-smaller waist measurement and a better outlook on his health). The article also highlights recent findings about the effectiveness of moderate, regular exercise (a key element in Lindora’s Lean for Life® program) for the loss of belly fat. Click here to download the entire article (PDF format)
|
|
|
The August 23, 2004 issue of Newsweek cover says it all: "When Fat Attacks: How Fat Cells are Waging War on your Health." While the world still searches for the "silver bullet," Newsweek tries to uncover the intricacies of the fat cells and why America is the fattest nation on earth.
|
|
|
In September, 2004, Lindora launched the new Metabolic Fitness Treatment Program™ (MFTP™). Pioneered by the Lindora medical team and clinical research staff, MFTP combines an innovative new assessment tool – the Metabolic Fitness Quotient™ (MFQ™) – with a new comprehensive treatment plan. The treatment plan uses state-of-the-art testing and diagnostics to provide a unique evaluation of your risk for heart disease, stroke, diabetes, abnormal cholesterol levels, metabolic syndrome and other preventable diseases. It then provides the clinical information you need to take an active role in improving your health through weight loss, exercise and other lifestyle changes. Using this information, ... read more
|
|
 |
|
|
 |
|